Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thorneycroft, K."'
Autor:
Parker, W.A.E., Orme, R.C., Hanson, J., Stokes, H.M., Bridge, C.M., Shaw, P.A., Sumaya, W., Thorneycroft, K., Petrucci, G., Porro, B., Judge, H.M., Ajjan, R.A., Rocca, B., Storey, R.F.
Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::92cc448dbb15d3271cb56562aa828d00
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parker WAE; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.; b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK., Orme RC; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.; b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK., Hanson J; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Stokes HM; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Bridge CM; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Shaw PA; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Sumaya W; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.; b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK., Thorneycroft K; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Petrucci G; c Institute of Pharmacology , Catholic University School of Medicine , Rome , Italy., Porro B; d Centro Cardiologico Monzino , Istituto di Ricovero e Cura a Carattere Scientifico Cardiologico Monzino , Milan , Italy., Judge HM; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom., Ajjan RA; e Leeds Institute of Cardiovascular and Metabolic Medicine , University of Leeds , Leeds , UK., Rocca B; c Institute of Pharmacology , Catholic University School of Medicine , Rome , Italy., Storey RF; a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.; b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.
Publikováno v:
Platelets [Platelets] 2019; Vol. 30 (2), pp. 148-157. Date of Electronic Publication: 2019 Feb 13.
